Home ›
Trademark Categories ›
Pharmaceuticals ›
2020 ›
EQ ›
EQRIVY
Trademark search for:
EQRIVY
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2020-10-05 — Application filed
2020-10-08 — Application filed
2020-11-19 — Application filed
2021-02-02 — Assigned to examiner
2021-02-03 — Final disposition recorded
2021-02-03 — Final disposition recorded
2021-02-03 — Final disposition recorded
2021-07-20 — Office action issued
2021-07-20 — Correspondence received in law office
2021-07-21 — Teas/email correspondence entered
2021-08-18 — Approved for pub - principal register
2021-09-01 — Notification of notice of publication e-mailed
2021-09-21 — Published for opposition
2021-09-21 — Official gazette publication confirmation e-mailed
2021-11-16 — Noa e-mailed - sou required from applicant
2022-03-21 — Sou teas extension received
2022-03-21 — Sou extension 1 filed
2022-03-21 — Sou extension 1 granted
2022-03-23 — Notice of approval of extension request e-mailed
2022-10-20 — Sou teas extension received
2022-10-20 — Sou extension 2 filed
2022-10-20 — Sou extension 2 granted
2022-10-22 — Notice of approval of extension request e-mailed
2023-03-22 — Sou teas extension received
2023-03-22 — Sou extension 3 filed
2023-03-22 — Sou extension 3 granted
2023-03-24 — Notice of approval of extension request e-mailed
2023-11-15 — Sou teas extension received
2023-11-15 — Sou extension 4 filed
2023-11-15 — Sou extension 4 granted
2023-11-17 — Notice of approval of extension request e-mailed
2024-05-14 — Sou extension 5 filed
2024-05-14 — Sou extension 5 granted
2024-05-14 — Sou teas extension received
2024-05-15 — Notice of approval of extension request e-mailed
2024-12-16 — Application abandoned
2024-12-16 — Application abandoned
2024-12-16 — Final status recorded
Owner Information
ADC Therapeutics SA
ADC Therapeutics SA
Correspondent
Tracy-Gene G. Durkin Sterne, Kessler, Goldstein & Fox P.L.L.C.
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
